GENE ONLINE|News &
Opinion
Blog

2018-05-02|

May 2, 2013: U.S. Research Team Published the First Genetic Test Predicting Surgery Efficacy

by GeneOnline
Share To

On May 2, 2013, the U.S. research team published a seven-year research report in the American Journal of Human Genetics, announcing the first genetic test to predict benefits of gastric bypass surgery, also known as Roux-en-Y gastric bypass (RYGB). The test results can be used to determine the long-term success rate of RYGB with up to 70% of accuracy. Discovery of the correlation between certain genes and the effect of RYGB stands for a strong evidence of how genetic factors influence patients’ response to surgery, and also represents a breakthrough in genetic technology on improving clinical medicne.

Reference
https://www.cell.com/ajhg/issue?pii=S0002-9297(13)X0006-0

Image Source
https://commons.wikimedia.org/wiki/File:Blausen_0776_Roux-En-Y_01.png

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Weekly News Highlights: Aug 21-25
2023-08-28
BIO 2022: Addressing Bottlenecks in Gene Therapy
2022-08-03
R&D
Transcriptional Programs Uncovering the Genetic Causes of Psychiatric Disorders
2022-03-01
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top